Balla v. Gambro, Inc.

560 N.E.2d 1043, 203 Ill. App. 3d 57, 148 Ill. Dec. 446
Appellate Court of Illinois·Decided September 10, 1990·No. 1-88-2955·Published·Cited by 15 cases

Opinion

560 N.E.2d 1043 (1990)
203 Ill. App.3d 57
148 Ill.Dec. 446

Roger J. BALLA, Plaintiff-Appellant,
v.
GAMBRO, INC., Gambro Lundia AB, Gambro Dialysatoren, KG, and David Maupin, Defendants-Appellees.

No. 1-88-2955.

Appellate Court of Illinois, First District, First Division.

September 10, 1990.

*1044 Alan O. Amos & Associates, P.C., Chicago (Alan O. Amos of counsel), for plaintiff-appellant Balla.

Pedersen & Houpt, P.C., Chicago (Arthur Sternberg, of counsel), for defendants-appellees.

Justice O'CONNOR delivered the opinion of the court:

Roger J. Balla ("Balla") an attorney, sued his previous employer, Gambro, Inc. ("Gambro"); its affiliate, Gambro Dialysatoren, KG ("Gambro Germany"); Gambro's corporate parent, Gambro Lundia, AB ("Gambro Sweden"); and Gambro's president, David Maupin ("Maupin"); alleging retaliatory discharge. The trial court entered summary judgment for Gambro et. al, holding that since Balla was an attorney, he was barred from bringing a retaliatory discharge claim. Balla appeals.

Gambro is a distributor of kidney dialysis equipment manufactured by Gambro Germany. Among the products manufactured and distributed are dialyzers, which filter excess fluid and toxic substances from the blood of patients with impaired or no kidney function. The manufacture and sale of dialyzers is regulated by the U.S. Food and Drug Administration ("FDA") under the U.S. Food, Drug and Cosmetic Act ("Act"), 21 U.S.C. § 331, et seq. (1988), and FDA regulations, 21 C.F.R. § 820.150-820.198 (1987).

Gambro hired Balla in March, 1980, as Manager of Personnel and General Counsel. According to Gambro's 1983 corporate organization chart, Balla also held the position of Manager of Regulatory Affairs.[1] The position of Manager of Regulatory Affairs was described as an individual who was "responsible for ensuring awareness of and compliance with federal, state and local laws and regulations affecting the company's operations and products." The position required a "B.S. degree plus 3-5 years experience in the medical device field plus 2 years experience in the area of governmental regulations."

By letter dated July, 1985, Gambro Germany informed Gambro that defective dialyzers would be shipped. Gambro Germany further advised Gambro that:

*1045 "For acute patients risk is that the acute uremic situation will not be improved in spite of the treatment, giving continuous high levels of potassium, phosphate and urea/creatine. The [chronic] patient may note the effect as a slow progression of the uremic situation and depending on the interval between medical check-ups the medical risk may not be overlooked." (emphasis added.)

At this time, Balla alleges that he informed Maupin that Gambro's sale of these dialyzers would have to be reported to the FDA.

Nevertheless, in a telex dated July 19, 1985, Maupin informed Gambro that "[w]e [Gambro] are going to sell the ... [defective dialyzers] to a unit that is not currently our customer but who buys only on price." In August, 1985, the dialyzers arrived at Gambro's facility. In Balla's deposition, he stated that as an individual as well as an attorney, he was of the opinion that "the dialyzers were misbranded and/or adulterated."

On September 4, 1985, Maupin terminated Balla from Gambro's employment. Later that day, Gambro shipped some of the defective dialyzers to customers. On September 5, 1985, Balla reported the defective shipment to the FDA. The FDA seized the shipment, and determined the product to be "adulterated within the meaning of section 501(h) [of the Food, Drug, and Cosmetic Act]."

Subsequently, Balla filed his complaint alleging retaliatory discharge and seeking monetary damages. Initially, the trial court dismissed the action against Maupin, Gambro Sweden, and Gambro Germany. Then, the court granted Gambro's summary judgment motion holding that Balla's complaint failed to state a cause of action pursuant to Herbster v. North American Company for Life and Health Insurance (1986), 150 Ill.App.3d 21, 103 Ill.Dec. 322, 501 N.E.2d 343, appeal denied (1987), 114 Ill.2d 545, 108 Ill.Dec. 417, 508 N.E.2d 728, cert. denied (1987), 484 U.S. 850, 108 S.Ct. 150, 98 L.Ed.2d 105, because Balla was an attorney. Balla appeals.

Balla argues that he has standing to bring a cause of action for retaliatory discharge, notwithstanding the Herbster decision. We agree. Retaliatory discharge is an exception to the general rule that an at-will employment relationship may be terminated at any time for any or no cause. Notwithstanding the at-will employment relationship, the law recognizes a cause of action when it is alleged that the employee was discharged in retaliation for his activities, and that the discharge was in contravention of a clearly mandated public policy. (Wheeler v. Caterpillar Tractor Co. (1985), 108 Ill.2d 502, 505, 92 Ill.Dec. 561, 485 N.E.2d 372, cert. denied (1986), 475 U.S. 1122, 106 S.Ct. 1641, 90 L.Ed.2d 187, Palmateer v. International Harvester Co. (1981), 85 Ill.2d 124, 134, 52 Ill.Dec. 13, 421 N.E.2d 876.) Accordingly, Balla has alleged that he was discharged because he opposed the distribution of allegedly "misbranded and/or adulterated dialyzers;" and that his discharge contravenes public policy.

Public policy clearly favors the prevention of interstate and intra-state distribution of "misbranded and/or adulterated dialyzers." This public policy is exemplified by federal and state statutes which criminalize the distribution of defective dialyzers. (21 U.S.C. § 331 et seq. (1988); Ill. Rev.Stat.1987 ch. 56-½, par. 501 et seq.) Moreover, "there is no public policy more important than the one favoring the effective protection of the lives and property of citizens." (Wheeler v. Caterpillar Tractor Co. (1985), 108 Ill.2d 502, 511, 92 Ill.Dec. 561, 485 N.E.2d 372, cert. denied (1986), 475 U.S. 1122, 106 S.Ct. 1641, 90 L.Ed.2d 187, Palmateer v. International Harvester Co. (1981), 85 Ill.2d 124, 132, 52 Ill.Dec. 13, 421 N.E.2d 876.) Therefore, Balla clearly alleged two public policies that support that his termination was wrongful: (1) a public policy which favors his refusal to engage in Gambro's alleged illegal activities; and (2) a public policy which favors the protection of citizens lives by opposing the distribution of allegedly "misbranded and/or adulterated dialyzers."

If Balla had been a layman-employee rather than an attorney-employee, there would be no question as to his standing to *1046 bring a cause of action for retaliatory discharge.

Free access — add to your briefcase to read the full text and ask questions with AI

Balla v. Gambro, Inc., 560 N.E.2d 1043, 203 Ill. App. 3d 57, 148 Ill. Dec. 446 (Ill. Ct. App. 1990).

560 N.E.2d 1043 (Balla v. Gambro, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Ausman v. Arthur Andersen, LLP
810 N.E.2d 566 (Appellate Court of Illinois, 2004)
Buckner v. Atlantic Plant Maintenance, Inc.
694 N.E.2d 565 (Illinois Supreme Court, 1998)
Henderson v. State
962 S.W.2d 544 (Court of Criminal Appeals of Texas, 1997)
Buckner v. O'Brien
Appellate Court of Illinois, 1997
Tyler v. Original Chili Bowl, Inc.
934 P.2d 1106 (Court of Civil Appeals of Oklahoma, 1997)
Leweling v. Schnadig Corp.
657 N.E.2d 1107 (Appellate Court of Illinois, 1995)
Haltek v. Village of Park Forest
864 F. Supp. 802 (N.D. Illinois, 1994)
Nordling v. Northern States Power Co.
478 N.W.2d 498 (Supreme Court of Minnesota, 1991)
Balla v. Gambro, Inc.
584 N.E.2d 104 (Illinois Supreme Court, 1991)
Rice v. Nova Biomedical Corp.
763 F. Supp. 961 (N.D. Illinois, 1991)